Join the Tezepelumab group to help and get support from people like you.
Tezepelumab News
Tezspire Approved for Self-Administration in the U.S. With a New Pre-filled Pen
Now Offers Patients the Choice of Administration at Home or in a Doctor's Office THOUSAND OAKS, Calif., Feb. 2, 2023 /PRNewswire/ – Amgen (NASDAQ:AMGN) and AstraZeneca today announced the U.S....
FDA Approves Tezspire (tezepelumab) for Severe Asthma
17 December 2021 – AstraZeneca and Amgen’s Tezspire (tezepelumab-ekko) has been approved in the US for the add-on maintenance treatment of adult and paediatric patients aged 12 years and older with s...